4164.SR Nahdi Medical Co. | SA15HG521213
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 11.679.926.610 | 10.959.045.970 | 6.58% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 6,84 | 6,42 | 6.43% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 6 | 6 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |